Metformin: all 1,377 studies that test it
Page 12 of 14. Open to participants first (169), then studies with results posted, then the rest; newest registration first within each.
- Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic SteatohepatitisCompletedNCT01650181Phase 4
- Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to InsulinWithdrawnNCT01638988Phase 3
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 DiabetesCompletedNCT01624116Not applicable
- Metformin-Dipyridamole Interaction TrialCompletedNCT01613755Phase 4
- The Metformin-FMD TrialCompletedNCT01610401Phase 4
- Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery DiseaseCompletedNCT01604213Phase 4
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered AloneCompletedNCT01595880Phase 1
- Metformin in Pregnancy in Women With Polycystic Ovary SyndromeCompletedNCT01594697Not applicable
- Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01593371Not applicable
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 DiabetesWithdrawnNCT01593137Phase 4
- Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerCompletedNCT01589367Phase 2
- Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary SyndromeCompletedNCT01587378Not applicable
- Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary SyndromeCompletedNCT01581814Phase 3
- Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical TrialCompletedNCT01573377Not applicable
- Metformin Plus Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01566799Phase 2
- A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes MellitusCompletedNCT01563120Phase 4
- Study of Metformin With Simvastatin for Men With Prostate CarcinomaWithdrawnNCT01561482Phase 2
- A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With VandetanibCompletedNCT01551615Phase 1
- Prospective Trial of Metformin - Chemoprevention RoleWithdrawnNCT01550900Not applicable
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With RanolazineCompletedNCT01546597Phase 1
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mgCompletedNCT01546558Phase 1
- Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus AtorvastatinStatus unknownNCT01544751Not applicable
- Temsirolimus in Combination With Metformin in Patients With Advanced CancersTerminatedNCT01529593Phase 1
- Metformin for the Treatment of Unexplained OligozspermiaStatus unknownNCT01529177Phase 4
- Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
- Spironolactone Plus Metformin in Polycystic Ovary SyndromeCompletedNCT01526616Not applicable
- Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With MetforminCompletedNCT01525823Phase 1
- Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01521624Not applicable
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsCompletedNCT01518101Phase 4
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesCompletedNCT01511172Phase 2
- Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin TabletsWithdrawnNCT01510522Phase 4
- Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes MellitusCompletedNCT01509001Phase 4
- A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508195Phase 1
- A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508182Phase 1
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCompletedNCT01490658Phase 1
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCompletedNCT01489644Phase 1
- Metformin in Obese Children and AdolescentsCompletedNCT01487993Phase 3
- Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate CancerWithdrawnNCT01478308Phase 2
- Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast CancerTerminatedNCT01477060Phase 2
- Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary SyndromeCompletedNCT01474967Not applicable
- Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 DiabetesCompletedNCT01465152Phase 4
- Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's EsophagusCompletedNCT01465113Early Phase 1
- A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy VolunteersCompletedNCT01463774Phase 1
- Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
- Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary SyndromeStatus unknownNCT01459445Not applicable
- Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
- Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.CompletedNCT01443221Phase 1
- Evaluation of Clinical Safety of Combining Metformin With Anticancer ChemotherapyCompletedNCT01442870Phase 1
- Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin ProducCompletedNCT01441869Phase 1
- Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic MarkersTerminatedNCT01440127Phase 1
- The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) TrialCompletedNCT01438723Phase 4
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
- Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes PatientsCompletedNCT01429818Phase 4
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01426399Phase 1
- Liraglutide and Heart Failure in Type 2 DiabetesCompletedNCT01425580Phase 2
- Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and AmenorrheaWithdrawnNCT01423487Not applicable
- Drug-Drug Interaction Study With Metformin and NizatidineCompletedNCT01409395Phase 1
- Drug-drug Interaction Study With Metformin and ImatinibCompletedNCT01404715Phase 1
- The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1CompletedNCT01400191Phase 4
- Pioglitazone and Metformin in Diabetic ChildrenCompletedNCT01396564Phase 1/2
- Metformin & Inflammation in Pre-diabetic ChildrenCompletedNCT01394887Phase 2/3
- Polycystic Ovary Syndrome Genetics and Treatment ResponseStatus unknownNCT01389778Not applicable
- The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced ObesityCompletedNCT01384279Not applicable
- Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mgStatus unknownNCT01367054Not applicable
- Therapeutic Monitoring of Metformin in Women With Polycystic Ovary SyndromeStatus unknownNCT01366391Phase 4
- Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive SubjectsStatus unknownNCT01364675Not applicable
- Metformin in Women With Type 2 Diabetes in Pregnancy TrialCompletedNCT01353391Phase 3
- Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)WithdrawnNCT01352026Phase 2
- Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes SplicingCompletedNCT01349387Not applicable
- Metformin in Postmenopausal Women With Metabolic SyndromeStatus unknownNCT01342744Phase 4
- The Effect of Metformin on the Correlation Between Hyperinsulinemia and HypertensionCompletedNCT01342614Not applicable
- Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid CancerCompletedNCT01341886Not applicable
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and InsulinCompletedNCT01341717Phase 4
- Metformin and Sitagliptin in Women With Previous Gestational DiabetesCompletedNCT01336322Phase 2
- Gene Expression Profiles and Metformin Efficacy in Type 2 DiabetesStatus unknownNCT01334684Not applicable
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)CompletedNCT01329016Phase 1/2
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01324180Phase 1
- Glucose Control in Severely Burned PatientsCompletedNCT01307306Not applicable
- BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed StatesWithdrawnNCT01305551Phase 1
- Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic PatientsStatus unknownNCT01300637Not applicable
- A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy SubjectsCompletedNCT01292993Phase 1
- Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)CompletedNCT01279512Phase 4
- Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy VolunteersCompletedNCT01274130Not applicable
- Metformin in Obese Non-diabetic Pregnant WomenCompletedNCT01273584Phase 2/3
- A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01273571Phase 1
- Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe HyperglycemiaCompletedNCT01267448Phase 4
- Effect of Metformin on Breast Cancer MetabolismCompletedNCT01266486Phase 2
- Metformin in Chronic Obstructive Pulmonary DiseaseCompletedNCT01247870Phase 4
- A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusStatus unknownNCT01245166Phase 3
- Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT01243385Phase 2
- A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian VolunteersCompletedNCT01237522Phase 4
- Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF CyclesCompletedNCT01233206Phase 4
- Reducing Antipsychotic-Induced Weight Gain in Children With MetforminCompletedNCT01231074Phase 1
- The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.CompletedNCT01228240Phase 4
- Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?CompletedNCT01215331Phase 3
- Metformin Combined With Chemotherapy for Pancreatic CancerCompletedNCT01210911Phase 2
- Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro FertilizationTerminatedNCT01208740Phase 4
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes MellitusStatus unknownNCT01206647Phase 4
- Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic PatientsCompletedNCT01206153Phase 4
- Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial CancerCompletedNCT01205672Early Phase 1